Characterization of an exosite binding inhibitor of matrix metalloproteinase 13
Lata T. Gooljarsingh(GlaxoSmithKline (United States)), Richard R. Gontarek(South College), Peter J. Tummino(Intarcia Therapeutics (United States)), Gregg B. Fields(Scripps Research Institute), Lusong Luo(Beijing Biocytogen (China)), Frank T. Coppo(GlaxoSmithKline (United States)), Ami S. Lakdawala(GlaxoSmithKline (United States))
Cited by 43
Related Papers
Genomic-sequence comparison of two unrelated isolates of the human gastric pathogen Helicobacter pylori
|Nature|1999|1.9k
EZH2 inhibition as a therapeutic strategy for lymphoma with EZH2-activating mutations
|Nature|2012|1.8k
Hydrolysis of Biological Peptides by Human Angiotensin-converting Enzyme-related Carboxypeptidase
|Journal of Biological Chemistry|2002|1.4k
Residence Time of Receptor−Ligand Complexes and Its Effect on Biological Function
|Biochemistry|2008|550